Literature DB >> 11471662

Total thyroidectomy: the procedure of choice for multinodular goitre.

A N Hisham1, A F Azlina, E N Aina, A Sarojah.   

Abstract

OBJECTIVE: To review our experience of total thyroidectomy for bilateral multinodular goitre.
DESIGN: Prospective open study.
SETTING: Teaching hospital, Malaysia.
SUBJECTS: 98 consecutive patients whose bilateral multinodular goitres were treated by total thyroidectomy, January 1998-November 1999. INTERVENTION: A revised technique of total thyroidectomy in which more attention than is customary was paid to the exposure and safety of the laryngeal nerves and the parathyroid glands. All patients had at least 1 parathyroid gland autotransplanted. MAIN OUTCOME MEASURES: Morbidity and mortality
RESULTS: There were no injuries to the recurrent laryngeal nerves and no patient developed persistent hypocalcaemia; 27/98 developed transient hypocalcaemia, but this had settled by 6 months postoperatively. 59 patients had persistent symptoms of pressure preoperatively, and these all resolved by 3 months postoperatively. 6 patients had occult malignant disease discovered on histological examination, and 3 developed minor wound infections.
CONCLUSIONS: Total thyroidectomy is the procedure of choice for bilateral multinodular goitres, provided that sufficient attention is paid to the preservation of the laryngeal nerves and the parathyroid glands.

Entities:  

Mesh:

Year:  2001        PMID: 11471662     DOI: 10.1080/110241501750243725

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  8 in total

1.  Indications for surgery and significance of unrecognized cancer in endemic multinodular goiter.

Authors:  Konstantinos Lasithiotakis; Evangelia Grisbolaki; Dimosthenis Koutsomanolis; Maria Venianaki; Ioannis Petrakis; Nikolaos Vrachassotakis; Emanuel Chrysos; Odysseas Zoras; George Chalkiadakis
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  Should subtotal thyroidectomy be abandoned in multinodular goiter patients from endemic regions requiring surgery?

Authors:  Tayfun Yoldas; Ozer Makay; Gokhan Icoz; Timur Kose; Gulten Gezer; Erkan Kismali; Sadık Tamsel; Sureyya Ozbek; Mustafa Yılmaz; Mahir Akyildiz
Journal:  Int Surg       Date:  2015-01

3.  Recurrence after total thyroidectomy for benign multinodular goiter.

Authors:  Kylie L Snook; Peter L H Stalberg; Stan B Sidhu; Mark S Sywak; Pamela Edhouse; Leigh Delbridge
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

4.  Risk factors for recurrent nodular goiter after thyroidectomy for benign disease: case-control study of 244 patients.

Authors:  Hélène Gibelin; Mauricio Sierra; Denis Mothes; Pierre Ingrand; Pierre Levillain; Corinne Jones; Sammy Hadjadj; Florence Torremocha; Richard Marechaud; Jacques Barbier; Jean-Louis Kraimps
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

Review 5.  Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review.

Authors:  Gaurav Agarwal; Vivek Aggarwal
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

6.  Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery.

Authors:  Antonio Ríos Zambudio; José Rodríguez; Juan Riquelme; Teresa Soria; Manuel Canteras; Pascual Parrilla
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

7.  Nontoxic Multinodular Goitre and Incidental Thyroid Cancer: What Is the Best Surgical Strategy?-A Retrospective Study of 2032 Patients.

Authors:  Krzysztof Kaliszewski; Beata Wojtczak; Jędrzej Grzegrzółka; Jacob Bronowicki; Sawsan Saeid; Bartłomiej Knychalski; Zdzisław Forkasiewicz
Journal:  Int J Endocrinol       Date:  2018-05-14       Impact factor: 3.257

8.  Total thyroidectomy as the single surgical option for benign and malignant thyroid disease: a surgical challenge.

Authors:  Ioannis Vassiliou; Aliki Tympa; Nikolaos Arkadopoulos; Fotios Nikolakopoulos; Thalia Petropoulou; Vassilios Smyrniotis
Journal:  Arch Med Sci       Date:  2013-02-18       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.